Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients.

Clin Exp Immunol. 2000 Aug;121(2):311-9. Unique Identifier : AIDSLINE MED/20389936
Vecchiarelli A; Monari C; Palazzetti B; Bistoni F; Casadevall A; Microbiology Section, Department of Experimental Medicine and; Biochemical Sciences, University of Perugia, Perugia, Italy.; vecchiar@unipg.it


Abstract: It is generally believed that neutrophils from HIV-infected patients are functionally competent, but several studies have shown impairment in neutrophil fungal killing and cytokine production. In this study we evaluated the ability of neutrophils from healthy donors and HIV-infected patients to produce IL-12 in response to stimulation with Candida albicans, lipopolysaccharide (LPS) and Cryptococcus neoformans (acapsular and encapsulated), with and without MoAb opsonization. Neutrophils from healthy donors secreted IL-12 in response to LPS or C. albicans but not in response to encapsulated or acapsular C. neoformans, regardless of MoAb opsonization. Surprisingly, neutrophils from HIV-infected patients demonstrated constitutive IL-12 production, although these cells were not responsive to LPS stimulation. The inability of MoAb to C. neoformans capsular polysaccharide to promote IL-12 production by neutrophils excludes phagocytosis and/or CD16 cross-linking in this process, and distinguishes neutrophils from monocytes. Our results provide additional evidence for cytokine dysregulation in neutrophils from HIV-infected patients. Furthermore, the IL-12 response of neutrophils and monocytes to CD16 stimulation appears to be different, suggesting differences in the role of these phagocytic cells during the inflammatory response.


Keywords: JOURNAL ARTICLE Adult AIDS-Related Opportunistic Infections/IMMUNOLOGY Bacterial Capsules/IMMUNOLOGY Candida albicans/IMMUNOLOGY Cryptococcus neoformans/IMMUNOLOGY Human HIV Infections/*IMMUNOLOGY Interleukin-12/*SECRETION Lipopolysaccharides/IMMUNOLOGY Neutrophils/*SECRETION Polysaccharides/IMMUNOLOGY Reverse Transcriptase Polymerase Chain Reaction Support, Non-U.S. Gov't Viral Load

KWDjournalarticleadultaids-relatedopportunisticinfections/immunologybacterialcapsules/immunologycandidaalbicans/immunologycryptococcusneoformans/immunologyhumanhivinfections/KWDimmunologyinterleukin-12/KWDsecretionlipopolysaccharides/immunologyneutrophils/KWDsecretionpolysaccharides/immunologyreversetranscriptasepolymerasechainreactionsupport,non-uKWDsKWDgov'tviralload
001130
A00B1161


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .